|
1 |
Potentiation of Lipotoxicity in Human EndoC‐βH1 β‐Cells by Glucose is Dependent on the Structure of Free Fatty Acids
Enthalten in Molecular nutrition & food research 02.02.2023. 13 S.
|
|
|
2 |
Die Bedeutung der Ferroptose und der Glutathionperoxidase 4 für die Dysfunktion und den Tod der Beta-Zellen des Pankreas während der Entwicklung der diabetischen Stoffwechsellage in Typ-1 und Typ-2 Diabetes mellitus
Krümmel, Bastian. - Hannover : Bibliothek der Medizinischen Hochschule Hannover, 2022
|
|
|
|
3 |
Site-specific intracellular generation and detection of hydrogen peroxide and protection against oxidative stress in insulin-producing cells
Laporte, Anna. - Greifswald : Universität Greifswald, 2019
|
|
|
|
4 |
Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes
Solimena, Michele. - Dresden : Technische Universität Dresden, 2019
|
|
|
|
5 |
Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes
Enthalten in Diabetologia 28.11.2017: 1-17
|
|
|
|
6 |
Einfluss des Pinealhormons Melatonin auf Calciumsignalproteine und pCREB in der pankreatischen β-Zelle von Säugern
Bazwinsky-Wutschke, Ivonne. - Halle, Saale : Universitäts- und Landesbibliothek Sachsen-Anhalt, 2014
|
|
|
|
7 |
Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes
Enthalten in Diabetologia Bd. 67, 7.9.2024, Nr. 11, date:11.2024: 2598-2599
|
|
|
|
8 |
Correction to: Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat
Enthalten in Journal of molecular medicine Bd. 99, 1.11.2021, Nr. 12, date:12.2021: 1831
|
|
|
|
9 |
MCPIP1 regulates the sensitivity of pancreatic beta-cells to cytokine toxicity
Enthalten in Cell death & disease Bd. 10, 10.1.2019, Nr. 1, date:1.2019: 1-17
|
|
|
|
10 |
Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes
Enthalten in BMC medicine Bd. 18, 28.2.2020, Nr. 1, date:12.2020: 1-14
|
|
Administration
